Suspected adverse reaction to compounded preparations prescribed for weight loss: two cases of cerebral venous thrombosis

2020 ◽  
Vol 13 (3) ◽  
pp. e233746 ◽  
Author(s):  
Beatrice Mainoli ◽  
Mariana Carvalho Dias ◽  
Patricia Canhão ◽  
Mário Miguel Rosa

We report two cases of cerebral venous thrombosis associated with the use of compounded preparations containing several active substances prescribed for weight loss. In both cases there is suspicion of additive/synergic interaction with oral contraceptives. The adverse drug reactions were considered serious, being life-threatening and causing hospitalisation for days.

2007 ◽  
Vol 33 (12) ◽  
pp. 2150-2157 ◽  
Author(s):  
Marieke Grenouillet-Delacre ◽  
Hélène Verdoux ◽  
Nicholas Moore ◽  
Françoise Haramburu ◽  
Ghada Miremont-Salamé ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-10 ◽  
Author(s):  
Wen-Lang Fan ◽  
Meng-Shin Shiao ◽  
Rosaline Chung-Yee Hui ◽  
Shih-Chi Su ◽  
Chuang-Wei Wang ◽  
...  

Adverse drug reactions (ADRs) remain a common and major problem in healthcare. Severe cutaneous adverse drug reactions (SCARs), such as Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) with mortality rate ranges from 10% to more than 30%, can be life threatening. A number of recent studies demonstrated that ADRs possess strong genetic predisposition. ADRs induced by several drugs have been shown to have significant associations with specific alleles of human leukocyte antigen (HLA) genes. For example, hypersensitivity to abacavir, a drug used for treating of human immunodeficiency virus (HIV) infection, has been proposed to be associated with allele 57:01 of HLA-B gene (terms HLA-B∗57:01). The incidences of abacavir hypersensitivity are much higher in Caucasians compared to other populations due to various allele frequencies in different ethnic populations. The antithyroid drug- (ATDs- ) induced agranulocytosis are strongly associated with two alleles: HLA-B∗38:02 and HLA-DRB1∗08:03. In addition, HLA-B∗15:02 allele was reported to be related to carbamazepine-induced SJS/TEN, and HLA-B∗57:01 in abacavir hypersensitivity and flucloxacillin induced drug-induced liver injury (DILI). In this review, we summarized the alleles of HLA genes which have been proposed to have association with ADRs caused by different drugs.


2012 ◽  
Vol 25 (1) ◽  
pp. 22-29 ◽  
Author(s):  
James O’Donnell

Anticoagulants are powerful and unavoidably dangerous drugs that must be carefully selected, monitored, and evaluated. Every patient undergoing treatment is at risk of excess bleeding, since the primary purpose of this class of drugs is to decrease clotting through a variety of biochemical and pharmacological mechanisms. Under the best of circumstances, significant numbers of patients (∼10%) experience toxicity on traditional warfarin oral anticoagulants. Beyond the obvious type A pharmacological toxicity, heparin products carry a seemingly paradoxical/novel risk of increased coagulopathy with limb- and life-threatening thromboembolic injuries (heparin-induced thrombocytopenia [HIT]). As a result of the great toxicity risk, many patients suffer injuries, and litigation is threatened or initiated, frequently against pharmacists and their employers. This article reviews the therapeutic use of old and novel anticoagulants, lists the types of litigation related thereto, and discusses the HIT risk associated with heparin products treatment. Litigation can result from adverse drug reactions and toxicity from anticoagulants.


Author(s):  
Mary Elizabeth Wilson

What is the difference between an allergic reaction and an adverse reaction? What are the signs and symptoms of an allergic reaction? All allergic reactions to a drug are adverse drug reactions, but adverse drug reactions also include many other kinds of reactions. Every antibiotic...


Author(s):  
Prochazka Vaclav ◽  
Prochazka Martin ◽  
Lubusky Marek ◽  
Prochazkova Jana ◽  
Hrbac Toma

Author(s):  
Marco Cosentino ◽  
Olivia Leoni ◽  
Cristina Oria ◽  
Donatella Michielotto ◽  
Enrica Massimo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document